By explicitly analyzing CRISPR screening in 53 CRC cell lines, TOP2A, CDK1, CDK7, and CDK9 presented the highest efficacies demonstrated by the most negative or toxic CERES effects (Figure S8). This evidence concerns the gene CDK1 and colorectal carcinoma.